Are all intracranial mass lesions always a contraindication for thrombolytic therapy?

Creative Commons License

Gullupinar B., ÇOLAK N., Bayram B.

HONG KONG JOURNAL OF EMERGENCY MEDICINE, cilt.21, sa.2, ss.98-102, 2014 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 2
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1177/102490791402100212
  • Dergi Adı: HONG KONG JOURNAL OF EMERGENCY MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.98-102
  • Anahtar Kelimeler: Adult, cardiogenic shock, meningioma, pulmonary embolism, treatment outcome, ACUTE PULMONARY-EMBOLISM, VENOUS THROMBOEMBOLISM, MANAGEMENT, DIAGNOSIS, REGISTRY, HEMORRHAGE, GUIDELINES, PHYSICIANS
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Thrombolytic therapy, is regarded as the first treatment choice in haemodynamically unstable patients with pulmonary embolism. Intracranial tumors have long been considered as a contraindication to thrombolytic therapy due to the risk of intracerebral haemorrhage. In this report, we presented a 76-year-old female patient with meningioma and massive pulmonary embolism who had received thrombolytic therapy despite a contraindication of intracranial mass. The patient completed the thrombolytic therapy without having complication.